当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

To treat or not to treat? That is the question

Lorraine Burgess

Age is a risk factor for both dementia and most cancers and we can hypothesis that we will see more and more people affected by both conditions over future decades. Individuals affected by both cancer and dementia pose unique challenges to healthcare professionals owing to complex factors as impaired mental capacity, consent issues, poor communication and issues of compliance when having to make decisions around oncology treatments. Adjusting to a cancer diagnosis when living with dementia can unfold a variety of emotional and practical responses to receiving news of the diagnosis of cancer and treatment options available and indeed of whether or not to offer or accept treatments. This can be a confusing, frustrating and distressing decision for those working in oncology services as well as for family carers and people living with dementia which may on occasion indicate treatment is not always perceived as in that persons best interest. Therefore the decision of whether to treat or not to treat comes with huge implications both ethically and in relation to quality of life outcomes. This presentation demonstrates the complexities and challenges involved in working as a dementia nurse consultant in a large UK oncology specialist treatment centre which have previously been unexplored.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。